Analyzing Real-World Data & Investigating Genotype-Phenotype Data to Support Precision Medicine Drug Development in Rare Disease, Upcoming Webinar Hosted by Xtalks
TORONTO (PRWEB) June 08, 2020 -- Join Leone Atkinson, MD, PhD, Executive Director, Rare Disease and Pediatrics Team, Covance, Fred Derosier, DO, Executive Director, Rare Disease and Pediatrics Team, Covance and Thomas Wells, MS, CEO & Cofounder, Precision Digital Health in a live webinar on Monday, June 22, 2020 at 10am EDT (3pm BST/UK). Attendees will learn about the potential role of expanded, longitudinal data sets in improving the diagnosis of patients, as well as the design and conduct of clinical trials.
Real-world data can help us understand rare disease patient populations at a fundamental level, but how can we leverage this information and incorporate multiple data sources to deepen our understanding of the natural history of a disease and better identify tangible targets for the development of precision medicines?
To support virtual mapping of disease progression and better understand comorbidities, longitudinal real-world data sets can help identify potential genotype-phenotype relationships and may provide supplementary information to the standard variant classification process of determining mutational pathogenicity.
Coupled with physician diagnostic coding from the patient care setting, advanced analyses of these disparate data could improve how our industry diagnoses patients, designs and conducts trials and enables more efficient development of targeted therapies.
Join this webinar for an in-depth discussion on predictive modeling with real-world data to better understand the patient journey in rare disease. The presenters will share their applications of real-world data against co-existing conditions documented by the ICD codes across longitudinal data subsets for individuals with specific mutations of interest. Learn how their exploratory analyses can help identify symptoms and biochemical parameters that may help patients and physicians reach earlier, more accurate diagnoses.
For more information or to register for this event, visit Analyzing Real-World Data & Investigating Genotype-Phenotype Data to Support Precision Medicine Drug Development in Rare Disease.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Sydney Perelmutter, Xtalks, +1 (416) 977-6555 x 352, [email protected]
Share this article